Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

1994 - ashpublications.org
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

[引用][C] Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S MACKINNON, L BARNETT, G HELLER… - Blood, 1994 - pascal-francis.inist.fr
Minimal residual disease is more common in patients who have mixed T-cell chimerism after
bone marrow transplantation for chronic myelogenous leukemia CNRS Inist Pascal-Francis …

[HTML][HTML] Minimal Residual Disease Is More Common in Patients Who Have Mixed T-Cell Chimerism After Bone Marrow Transplantation for Chronic Myelogenous …

S Mackinnon, L Barnett, G Heller, RJ O'Reilly - Blood, 1994 - Elsevier
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.

S Mackinnon, L Barnett, G Heller, RJ O'Reilly - Blood, 1994 - europepmc.org
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

[引用][C] Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S MACKINNON - Blood, 1994 - cir.nii.ac.jp
Minimal residual disease is more common in patients who have mixed T-cell chimerism after
bone marrow transplantation for chronic myelogenous leukemia | CiNii Research CiNii 国立 …

Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S Mackinnon, L Barnett, G Heller, RJ O'Reilly - Blood, 1994 - pubmed.ncbi.nlm.nih.gov
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

[引用][C] Minimal residual disease is more common in patient who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S MACKINNON - Blood, 1994 - cir.nii.ac.jp
Minimal residual disease is more common in patient who have mixed T-cell chimerism after
bone marrow transplantation for chronic myelogenous leukemia | CiNii Research CiNii 国立 …

[引用][C] Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S MACKINNON, L BARNETT, G HELLER… - …, 1994 - Americain Society of Hematology